Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06318130
Other study ID # LEAD-LBP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date June 30, 2025

Study information

Verified date January 2024
Source National University Hospital, Singapore
Contact Eugene Tan, MBBS
Phone +6567795555
Email esjtan@nus.edu.sg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial seeks to evaluate the performance of the extendable helix, stylet-driven pacing lead (EHL) compared to the fixed helix, lumenless pacing lead (FHL) during left bundle branch pacing (LBBP), with respect to enduring left bundle branch capture on follow-up, incidence of acute lead failure, pacing characteristics including QRS duration, pacing thresholds, R-wave amplitudes and lead impedance, and finally, safety profile during LBBP implantation. These data will guide future lead selection during LBBP implantation in achieving improved procedural success and optimal lead performance.


Description:

This study is a single-blind, randomised controlled trial, aimed at evaluating the performance of the extendable helix, stylet driven pacing lead (EHL) compared to the fixed helix, lumenless pacing lead (FHL) during left bundle branch pacing (LBBP). The study is a multicentre study across 3 major hospitals in Singapore, and LBBP performed by independent electrophysiologists experienced in performing LBBP. The primary objective of the study is to determine differences in incidence of loss of left bundle capture by pacing lead design (FHL vs EHL). The secondary objectives are to determine if lead design affects frequency of lead failure during implantation, investigate differences in short- and medium-term LBBP parameters on follow-up by lead design, and evaluate differences in safety profile between FHL and EHL in LBBP. This study aims to recruit a target of 210 patients. A previous retrospective study found a loss of LB capture rate of 9% with FHL and 25% with EHL. A sample size of 170 will be required for a type-1 error rate of 5% and power of 80%. Accounting for a dropout rate of 20%, a total of 210 patients will be recruited (105 per group). Eligible subjects will be randomised to either the FHL or the EHL arm. The randomisation list will be generated with a computer-generated sequence in permuted blocks of 4, stratified by centre, to ensure a final allocation ratio of 1:1.


Recruitment information / eligibility

Status Recruiting
Enrollment 210
Est. completion date June 30, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility Inclusion Criteria: 1. Fulfil current indications for pacemaker therapy according to international guideline recommendations: 1. Symptomatic sinus bradycardia/sinus node dysfunction or AV block requiring pacemaker insertion. 2. Symptomatic heart failure, left ventricular ejection fraction (LVEF) <35%, left bundle branch block and QRS duration >120ms. 3. Symptomatic heart failure, left ventricular ejection fraction (LVEF) <35%, right bundle branch block and QRS duration >150ms. 4. LVEF <50% with significant anticipated ventricular pacing requirement of =20%. 2. Age =21 years old 3. Able to provide informed consent 4. Planned LBBP implantation Exclusion Criteria: 1. Severe tricuspid regurgitation or previous tricuspid valve intervention requiring implantation of left ventricular lead in the coronary sinus. 2. Unable to provide informed consent. 3. Pregnant women. 4. <21 years of age.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Fixed helix, lumenless pacing lead.
Patients will be randomised to the fixed helix, lumenless pacing lead design during LBBP implantation.
Extendable helix, stylet-driven pacing lead.
Patients will be randomised to the extendable helix, stylet-driven pacing lead design during LBBP implantation.

Locations

Country Name City State
Singapore National University Heart Centre Singapore Singapore

Sponsors (1)

Lead Sponsor Collaborator
National University Hospital, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of loss of left bundle branch capture Loss of LBB capture is defined as the absence of the terminal r/R' complex in V1 during initial threshold interrogations at high pacing outputs and the absence of transitions in paced QRS morphology with decreasing pacing outputs until loss of myocardial capture. 12 months
Secondary Incidence of acute lead failure Acute lead failure is defined as defined as structural damage to the pacing lead during implant necessitating the use of a new pacing lead. 12 months
Secondary Serial changes in pacing thresholds (V) To compare the differences in pacing thresholds (V) at implant and at 12 months after LBBP implant. 12 months
Secondary Serial changes in R-wave amplitude (mV) To compare the differences in R-wave amplitude (mV) at implant and at 12 months after LBBP implant. 12 months
Secondary Serial changes in lead impedance (ohm) To compare the differences in lead impedance (ohm) at implant and at 12 months after LBBP implant. 12 months
Secondary Serial changes in QRS duration (ms) To compare the differences in QRS duration (ms) at implant and at 12 months after LBBP implant. 12 months
Secondary Incidence of peri-procedural complications Complications intraprocedurally and on follow-up will be evaluated, including lead dislodgement, lead fracture during implant, septal perforation, septal vein/arterial injury, pneumothorax, pericardial effusion, wound/pacemaker infection. 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05015660 - Conduction System Pacing With Left Bundle Branch Pacing as Compared to Standard Right Ventricular Pacing N/A
Completed NCT04323670 - Master Study Investigating the Guiding Catheter Selectra 3D N/A
Recruiting NCT02931760 - Placement Of Cardiac PacemaKer Trial (POCKET)-RCT N/A
Completed NCT03727542 - Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels N/A
Not yet recruiting NCT06045143 - Right Ventricular Septal Versus Apical Pacing: Echocardiographic Study
Completed NCT04163965 - Data Collection for Pacemaker Recognition Through Capacitive ECG N/A
Not yet recruiting NCT06377046 - Accelerated Pacing in Patients Undergoing Pace-and-ablate Strategy With LBBAP: a Randomized Controlled Pilot Trial N/A
Completed NCT04269733 - Risk of Pacing-induced Cardiomyopathy
Completed NCT06068699 - Postcards to Improve Remote Monitoring Adherence Among Veterans N/A
Recruiting NCT05868616 - Non-Invasive Method for Evaluation of Cardiac Resynchronization Therapy
Recruiting NCT06371846 - Comparative Study of the Surface Electrocardiogram Signals During the Implantation of Conduction System Pacing Devices
Recruiting NCT03357926 - Prospective Database for Prediction of Atrial Fibrillation in Pacemaker and ICD Patients
Recruiting NCT05884359 - Left Bundle Branch Area Mapping for Conduction System Pacing
Completed NCT04372654 - Pilot Study Evaluating the Safety of Electroducer Sleeve Medical Device for Temporary Cardiac Stimulation During Percutaneous Cardiovascular Interventions, in All Kind of Patients N/A
Not yet recruiting NCT05695534 - Use of VR in Patients' Education Prior to Implantation of PPM N/A
Completed NCT04067024 - Evaluation of the Effectiveness of the Supraclavicular Block Associated With a Pecs Blocks I to Ensure Analgesia When Placing a Pacemaker N/A
Recruiting NCT04416958 - Pacing to Maintain Physiologic Ventricular Activation
Completed NCT05222672 - Electrical and Mechanical Activation in PAcing The His Bundle Conduction sYstem
Enrolling by invitation NCT04383392 - QoL Between CIEDs With and Without Rate Adaptive Pacing N/A
Completed NCT04957771 - Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation N/A